Orphazyme As Stock Net Income
ORPHA Stock | DKK 1,047 52.80 4.80% |
Orphazyme AS fundamentals help investors to digest information that contributes to Orphazyme's financial success or failures. It also enables traders to predict the movement of Orphazyme Stock. The fundamental analysis module provides a way to measure Orphazyme's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orphazyme stock.
Orphazyme |
Orphazyme AS Company Net Income Analysis
Orphazyme's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Orphazyme Net Income | (626.54 M) |
Most of Orphazyme's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orphazyme AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Orphazyme AS reported net income of (626.54 Million). This is 283.58% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all Denmark stocks is significantly higher than that of the company.
Orphazyme Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orphazyme's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Orphazyme could also be used in its relative valuation, which is a method of valuing Orphazyme by comparing valuation metrics of similar companies.Orphazyme is currently under evaluation in net income category among related companies.
Orphazyme Fundamentals
Return On Equity | -4.87 | |||
Return On Asset | -1.33 | |||
Profit Margin | (2.76) % | |||
Operating Margin | (15.38) % | |||
Current Valuation | (12.81 M) | |||
Shares Outstanding | 35.31 M | |||
Shares Owned By Insiders | 1.36 % | |||
Shares Owned By Institutions | 8.13 % | |||
Price To Book | 0.47 X | |||
Price To Sales | 1.05 X | |||
Revenue | 36.19 M | |||
Gross Profit | 36.19 M | |||
EBITDA | (603.91 M) | |||
Net Income | (626.54 M) | |||
Cash And Equivalents | 726.93 M | |||
Cash Per Share | 20.80 X | |||
Total Debt | 2.48 M | |||
Debt To Equity | 0.11 % | |||
Current Ratio | 4.70 X | |||
Book Value Per Share | 2.21 X | |||
Cash Flow From Operations | (602.57 M) | |||
Earnings Per Share | (17.94) X | |||
Target Price | 108.0 | |||
Beta | 0.82 | |||
Market Capitalization | 30.82 M | |||
Total Asset | 173.23 M | |||
Z Score | -2.7 | |||
Net Asset | 173.23 M |
About Orphazyme Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orphazyme AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orphazyme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orphazyme AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Orphazyme in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Orphazyme's short interest history, or implied volatility extrapolated from Orphazyme options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orphazyme AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Orphazyme AS information on this page should be used as a complementary analysis to other Orphazyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Orphazyme Stock analysis
When running Orphazyme's price analysis, check to measure Orphazyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme is operating at the current time. Most of Orphazyme's value examination focuses on studying past and present price action to predict the probability of Orphazyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme's price. Additionally, you may evaluate how the addition of Orphazyme to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |